PSPablo Sanchez-Salcedo

Pablo Sanchez-Salcedo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pablo Sanchez-Salcedo has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Asbestos‐Related Respiratory Diseases in Spain: Insights From the Spanish Registry

    by Galo Granados, María‐Jesús Cruz, Isabel Urrutia‐Landa, Olaia Bronte‐Moreno, Sandra Dorado‐Arenas, Carmen Diego‐Roza, Irene Nieto‐Codesido, Santiago Rodríguez‐Segade‐Alonso, Raquel Ruiz‐Ferreras, Ana Fernández‐Tena, et al.

    Introduction: Although many Spanish workers have been exposed to asbestos, asbestos‐related diseases (ARD) have not been widely reported in this country. The aim of the present study was to analyze the data recorded in the Spanish Registry of asbestos‐derived diseases. Methods: A retrospective observational study was conducted based on data reported between September 19, 2018, and May 15, 2023, covering 11 Spanish autonomous communities. Variables included demographic data, type of exposure, symptoms, pulmonary function tests, radiological studies, and initial and follow‐up diagnoses. Results: One thousand seven hundred and twenty‐one cases were reported, with a mean age of 75.2 years. The majority were men (96.7%) and were smokers or former smokers (78.8%). Occupational exposure accounted for 98.3% of cases, mainly in the naval sector (70%). Pleural plaques were the most prevalent diagnosis (82.1%), followed by asbestosis (14.9%) and lung cancer (11%). During follow‐up, 181 new diagnoses were made, including lung cancer (23.76%) and mesothelioma (11.6%). The overall mortality rate was 13.4%, with lung cancer being the leading cause of death. Conclusions: This study provides a first overview of ARD in Spain. The most notable findings are the importance of shipyards as a source of exposure, the predominance of pleural plaques and the number of new diagnoses made during the follow‐up, and the need for continuous surveillance and early diagnosis to mitigate asbestos‐related adverse effects.


  • Open Access

    Prevalence and burden of bronchiectasis in a lung cancer screening program

    by Maria Sanchez-Carpintero Abad, Pablo Sanchez-Salcedo, Juan P. De-Torres, Ana B. Alcaide, Luis M. Seijo, Jesus Pueyo, Gorka Bastarrika, Javier J. Zulueta, Arantza Campo

    The prevalence of bronchiectasis in the general population and in individuals undergoing lung cancer screening with low dose computed tomography (LDCT) is unknown. The aim of this study is to estimate the prevalence and impact of bronchiectasis in a screening lung cancer program. 3028 individuals participating in an international multicenter lung cancer screening consortium (I-ELCAP) were selected from 2000 to 2012. Patients with bronchiectasis on baseline CT were identified and compared to selected controls. Detection of nodules, need for additional studies and incidence of cancer were analyzed over the follow-up period. The prevalence of bronchiectasis was 11.6%(354/3028). On the baseline LDCT, the number of subjects with nodules identified was 189(53.4%) in patients with bronchiectasis compared to 63(17.8%) in controls (pvs. 88(12.17%) for controls (p = 0.008).The incidence rate of lung cancer during follow-up was 6.8/1000 and 5.1/1000 person-years for each group respectively (p = 0.62) Bronchiectasis are common among current and former smokers undergoing lung cancer screening with LDCT. The presence of bronchiectasis is associated with greater incidence of new nodules and false positives on baseline and follow-up screening rounds. This leads to an increase need of diagnostic tests, although the lung cancer occurrence is not different.


  • Open Access

    Emphysema phenotypes and lung cancer risk

    by Jessica González, Claudia I. Henschke, David F. Yankelevitz, Luis M. Seijo, Anthony P. Reeves, Rowena Yip, Yiting Xie, Michael Chung, Pablo Sánchez-Salcedo, Ana B. Alcaide, et al.

    To assess the relationship between lung cancer and emphysema subtypes. Airflow obstruction and emphysema predispose to lung cancer. Little is known, however, about the lung cancer risk associated with different emphysema phenotypes. We assessed the risk of lung cancer based on the presence, type and severity of emphysema, using visual assessment. Seventy-two consecutive lung cancer cases were selected from a prospective cohort of 3,477 participants enrolled in the Clínica Universidad de Navarra’s lung cancer screening program. Each case was matched to three control subjects using age, sex, smoking history and body mass index as key variables. Visual assessment of emphysema and spirometry were performed. Logistic regression and interaction model analysis were used in order to investigate associations between lung cancer and emphysema subtypes. Airflow obstruction and visual emphysema were significantly associated with lung cancer (OR = 2.8, 95%CI: 1.6 to 5.2; OR = 5.9, 95%CI: 2.9 to 12.2; respectively). Emphysema severity and centrilobular subtype were associated with greater risk when adjusted for confounders (OR = 12.6, 95%CI: 1.6 to 99.9; OR = 34.3, 95%CI: 25.5 to 99.3, respectively). The risk of lung cancer decreases with the added presence of paraseptal emphysema (OR = 4.0, 95%CI: 3.6 to 34.9), losing this increased risk of lung cancer when it occurs alone (OR = 0.7, 95%CI: 0.5 to 2.6). Visual scoring of emphysema predicts lung cancer risk. The centrilobular phenotype is associated with the greatest risk.